BMI View: The frontier Myanmar pharmaceuticals and healthcare market boasts high potential and is
poised to see significant reforms over the coming years, although in the near term it will remain a high-risk
venture for most multinational drugmakers given prevailing e ..."
BMI View: The influx of private healthcare providers into Myanmar will continue, creating positive spillover
effects for both medical device and pharmaceutical firms. This attraction is due to the combination of a
large unmet demand for medical services in the country ..."
BMI View: High out-of-pocket payments will continue to account for the majority of health expenditure in
Myanmar as we believe that coverage would be limited even if the country were to introduce universal
health coverage due to lack of resources. Nevertheless, strong ..."
BMI View: Out-of-pocket payments will remain a key source of healthcare financing in Myanmar over the
medium term. Central to this view will be the slow uptake of private health insurance as the sub-sector
remains new to the country and has a premium structure that is ..."
BMI View: New investment reforms lifting restrictions on the foreign funding of medicine production will
make Myanmar an attractive market to international generic drugmakers. This is due to the opportunity of
securing a first-mover advantage in this frontier market, ..."
BMI View: Non-governmental organisations will continue to expand healthcare access in Myanmar - a
boon for the country's pharmaceutical market. However, the country's poor protection of intellectual
property, a weak healthcare system and political instability continues to pose ..."
BMI View: While the current medical gap will attract some foreign investors into Myanmar, we highlight
that the lack of basic infrastructure and political instability will potentially affect the growth of the
Headline Expenditure Projections
? Pha ..."
BMI View: The considerable increase in government health expenditure in 2012 highlights Myanmar's
commitment to improving healthcare. However, there are several barriers to the improvement of medical
services, such as limited funding for healthcare, a lack of basic re ..."
BMI View: Commercial opportunities in Myanmar's healthcare sector are largely derived from its large
unmet medical needs and underinvestment. However, we maintain that significant improvements are
required if Myanmar is to realise its ambitious public health insurance ..."
BMI View: Despite strong growth potential, Myanmar remains as one of the least attractive country in Asia
Pacific due to its small market size and general low spending on healthcare and pharmaceuticals. We
expect investors to turn to Myanmar only when the country has ..."